Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Infusion of L-Ornithine L-aspart is as Effective as Nonabsorbable Disaccharides in the Management of Acute Hepatic Encephalopathy.

NCT01041755 is registered in ClinicalTrials.gov with Centro Regional para el Estudio de las Enfermedades Digestivas as lead sponsor.

NCT NCT01041755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01041755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Infusion of L-Ornithine L-aspart is as Effective as Nonabsorbable Disaccharides in the Management of Acute Hepatic Encephalopathy.
Lead sponsor
Centro Regional para el Estudio de las Enfermedades Digestivas
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2011
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy